# A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)

> **NCT01756612** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 551 (actual)

## Conditions studied

- Renal Anemia of Chronic Kidney Disease

## Interventions

- **DRUG:** Methoxy Polyethylene Glycol-Epoetin Beta

## Key facts

- **NCT ID:** NCT01756612
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-21
- **Primary completion:** 2015-03-25
- **Final completion:** 2015-03-25
- **Target enrollment:** 551 (ACTUAL)
- **Last updated:** 2019-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01756612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01756612, "A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01756612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*